Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 203.6 | 156.9 | 89.1 | 82.6 |
| Revenue growth | 29.7% | 76.1% | 7.9% | |
| Cost of goods sold | 47.4 | 33.3 | 27.1 | 24.9 |
| Gross profit | 156.2 | 123.6 | 62.0 | 57.7 |
| Gross margin | 76.7% | 78.8% | 69.5% | 69.8% |
| Sales and marketing | 104.1 | 60.6 | 47.8 | 47.0 |
| Research and development | 34.8 | 19.3 | 15.7 | 14.3 |
| General and administrative | 40.9 | 21.8 | 14.6 | 13.3 |
| EBIT | -23.6 | 21.8 | -16.1 | -16.1 |
| EBIT margin | -11.6% | 13.9% | -18.1% | -19.5% |
| Pre-tax income | -24.5 | 21.1 | -17.2 | -17.4 |
| Income taxes | -0.3 | 0.3 | 0.4 | 0.2 |
| Tax rate | 1.2% | 1.4% | | |
| Net income | -24.8 | 15.1 | -32.3 | -20.6 |
| Net margin | -12.2% | 9.6% | -36.3% | -25.0% |
| |
| Diluted EPS | ($0.57) | $0.93 | ($3.68) | ($2.50) |
| Shares outstanding (diluted) | 43.6 | 16.2 | 8.8 | 8.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|